Deal Snapshot
CORTEVA AGRISCIENCE TO INVEST IN ISRAEL-BASED BIOLOGICALS COMPANY LAVIE BIO
Tuesday 13 August 2019

Delaware, US-based agriculture company Corteva, Inc. (NYSE: CTVA) has invested in Israel-based Lavie Bio, an agriculture biologicals subsidiary of biotechnology company Evogene Ltd., (NASDAW: EVGN) (TASE: EVGN), the company said.
The transaction includes the exchange of all shares of Corteva's wholly owned subsidiary Taxon Biosciences along with an equity investment by Corteva in Lavie. As consideration for the Taxon Biosciences shares and equity investment, Corteva will be issued approximately 30% of Lavie's equity while Evogene will hold approximately 70% of Lavie's equity.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 13/08/2019
Target: Lavie Bio/30% stake
Country: Israel
Sector: Biotechnology
Type: Stakebuilding
Financing: Stock
Status: Agreed
Vendor: Evogene Ltd
Buyer: Corteva, Inc.
Comment:


Options